THE LYNNE COHEN PREVENTIVE CARE symposium
FOR WOMEN'S CANCERS FUNDED AT USC/NORRIS CANCER CENTER
LOS ANGELES, CA, APRIL 9, 2001 - The Lynne Cohen Foundation for Ovarian
Cancer Research has made a five-year, $500,000 grant to USC/Norris
Comprehensive Cancer Center in Los Angeles to fund The Lynne Cohen
Preventive Care symposium for Women's Cancers.
The pilot project will be a unique screening and Clinical care
service for women at high risk, or with increased risk, for ovarian,
breast and other women's cancers (e.g., endometrial, cervical, tubal).
Lynda Roman, MD, Assistant Professor of Obstetrics and Gynecology
and Chief of Gynecologic Oncology, and Jim Waisman, MD, Associate
Professor of Medical Oncology, will co-direct the symposium, which
is housed within the Harold E. and Henrietta C. Lee Breast Center
at USC/Norris Cancer Hospital. The Lee Breast Center unites the latest
medical technology with Clinical expertise, emotional support and
compassionate care. Women referred to the Lynne Cohen symposium will
receive state-of-the-art preventive care and early detection screening.
A thorough risk assessment, in-depth medical history, as well as routine
and advanced screening examinations (physical and laboratory) will
be offered to all participants. Women who are determined to have increased
risk will receive continued monitoring and access to Clinical trials.
The program is geared to women having any of the following: A BRCA
1 or 2 mutation; a first-degree (mother, sister, daughter) relative
with breast and/or ovarian cancer or multiple family members with
breast and/or ovarian cancer; a close (not necessarily first-degree)
family relative diagnosed with early-age-onset breast or ovarian cancer;
a breast biopsy with atypical cells or lobular carcinoma in-situ;
a diagnosis of breast or ovarian cancer, one of which increases the
risk for the other; or Ashkenazi Jewish descent.
The project will provide the women in the study with a focused educational
component, which will help them to make informed choices about risk
reduction, genetic testing, preventive measures, and lifestyle issues.
The symposium will also offer advanced and investigational screening
methods for early detection as well as access to Clinical trials
in cancer symposium and treatment at USC/Norris Cancer Center.
The Lynne Cohen Foundation for Ovarian Cancer Research is a unique
nonprofit foundation that raises funds for cutting-edge medical research
in the women's healthcare field. Created in 1998 in memory of Lynne
Cohen by her three daughters (in their twenties), The Lynne Cohen
Foundation is dedicated to finding an early detection test for ovarian
cancer, to establishing high risk symposiums for women with family
members who have been diagnosed with ovarian and/or breast cancer,
and to finding better Clinical treatments for women struggling
with the disease. The sisters' mission is to keep their mom's memory
alive by helping other women in her name. A recent recipient of the
Reader's Digest 2001 Health Heroes Award, Foundation President Amy
Cohen, says, "We are committed to making an impact on women's healthcare
- to changing the outcome for every woman who receives a diagnosis
of ovarian cancer - to helping as many women as possible, at every
conceivable stage of disease, including preventive care."
Ovarian cancer is considered the most deadly gynecological cancer,
striking 26,000 women and killing approximately 14,000 every year
in the United States. Presently, there is no early detection test
for ovarian cancer. As a result, 75 percent of the women diagnosed
have late stage disease and only a 12 percent chance of surviving
five years. The Lynne Cohen Foundation is entering the arena of preventive
care precisely because of its desire to change those statistics. Earlier
this year, the Foundation funded The Lynne Cohen Cancer Screening
& symposium Project for High Risk Women at NYU Medical Center in New
York.
For more information, please contact:
Trudy Harris
The Lynne Cohen Foundation
310.571.9126
Brenda Maceo
USC/Norris Cancer Center
323.442.2830
BACK TO PRESS ROOM
MAIN |
|